Impact of CYP2C19 Variants on Clinical Efficacy of Clopidogrel and 1-Year Clinical Outcomes in Coronary Heart Patients Undergoing Percutaneous Coronary Intervention

The impact of pharmacogenetic variants of cytochrome P450 2C19 (CYP2C19) on clopidogrel-mediated effects on platelet inhibition, inflammatory response and endothelial function, as well as risk of major adverse cardiovascular events (MACE), in coronary heart patients undergoing percutaneous coronary...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Hong, Qu, Qiang, Chen, Zhen-Fan, Tan, Sheng-Lan, Zhou, Hai-Jun, Qu, Jian, Chen, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121225/
https://www.ncbi.nlm.nih.gov/pubmed/27932982
http://dx.doi.org/10.3389/fphar.2016.00453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121225/
https://www.ncbi.nlm.nih.gov/pubmed/27932982
http://dx.doi.org/10.3389/fphar.2016.00453

Ejemplares similares